SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-16-013530
Filing Date
2016-05-31
Accepted
2016-05-31 16:05:25
Documents
5
Period of Report
2016-07-05
Effectiveness Date
2016-05-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2228801zdef14a.htm DEF 14A 324152
2 G531997.JPG g531997.jpg GRAPHIC 12256
3 G777693.JPG g777693.jpg GRAPHIC 7805
4 G119182BGI001.JPG g119182bgi001.jpg GRAPHIC 81328
5 G119182BGI002.JPG g119182bgi002.jpg GRAPHIC 69305
  Complete submission text file 0001047469-16-013530.txt   560818
Mailing Address 1098 HAMILTON COURT MENLO PARK CA 94025
Business Address 1098 HAMILTON COURT MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: DEF 14A | Act: 34 | File No.: 001-37411 | Film No.: 161685891
SIC: 2834 Pharmaceutical Preparations